Central Lab Market Analysis, Demand And Outlook 2025- 2034

For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.

What is the forecasted revenue size of the central lab industry by 2029?

The central lab market size has grown strongly in recent years. It will grow from $3.06 billion in 2024 to $3.31 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increased clinical trials growth, growth in drug development activities, regulatory compliance, increased healthcare research, growth in diagnostic testing.

The central lab market size is expected to see strong growth in the next few years. It will grow to $4.54 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing personalized healthcare, increasing biomarker research, increasing demand for telemedicine and remote monitoring, global health challenges, growing demand for precision diagnostics. Major trends in the forecast period include technological advancements, innovative solutions, strategic collaborations.

Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7317&type=smp

Which industry-specific innovations are acting as key drivers for the central lab market?
The rise in the number of clinical trials is expected to drive the central lab market going forward. A clinical trial is a type of research study that is aimed at evaluating a new treatment, a new drug, or a medical device’s safety and effectiveness. Pharmaceutical and biotechnology companies outsource central labs for testing, development, and production of new products. For instance, in November 2023, according to the Association of the British Pharmaceutical Industry, a UK-based trade association, the total number of industry-sponsored clinical trials initiated in the UK increased slightly by 4.3%, rising from 394 trials in 2021 to 411 in 2022. Therefore, the rise in the number of clinical trials will promote the central lab market.

Which segment currently leads the central lab market in terms of revenue share?
The central lab market covered in this report is segmented –

1) By Service Type: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology or Histology, Specimen Management And Storage, Special Chemistry Services, Other Service Types
2) By Test Type: Human And Tumor Genetics, Clinical Chemistry, Medical Microbiology And Cytology, Other Esoteric Tests
3) By End-User: Pharmaceutical Companies, Academic And Research Institutes, Biotechnology Companies

Subsegments:
1) By Genetic Services: DNA Sequencing, Genotyping, Gene Expression Analysis
2) By Biomarker Services: Biomarker Discovery, Biomarker Validation, Pharmacodynamic Biomarker Testing
3) By Microbiology Services: Bacterial Identification and Susceptibility Testing, Virology Testing, Mycology and Parasitology Testing
4) By Anatomic Pathology or Histology: Tissue Sample Analysis, Immunohistochemistry (IHC), Slide Preparation and Staining
5) By Specimen Management and Storage: Biorepository Services, Sample Collection and Handling, Long-Term Sample Storage
6) By Special Chemistry Services: Toxicology Testing, Metabolomics, Hormonal Assays
7) By Other Service Types: Hematology Testing, Coagulation Testing, Flow Cytometry Services

View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/central-lab-global-market-report

Which sustainability trends are emerging in the central lab market?
Major companies operating in the central lab market are focusing on developing innovation, such as comprehensive diagnostic services for various cancer diagnostic services. Comprehensive diagnostic services refer to a wide range of medical tests and evaluations designed to assess and diagnose various health conditions. For instance, in June 2022, Karkinos Healthcare, an India-based healthcare company focused on providing innovative solutions in cancer care, launched the Advanced Centre for Cancer Diagnostics and Research to revolutionize cancer diagnostics and treatment. The Advanced Centre for Cancer Diagnostics and Research serves as a central laboratory for global oncology networks, focusing on molecular and genomic analysis to enhance personalized targeted therapy and predict treatment responses. It offers comprehensive diagnostic services, including histopathology and gene sequencing, to improve early detection and treatment options.

Who are the top competitors in the global central lab market?
Major companies operating in the central lab market include Celerion Inc., Cerba Research, Cirion Biopharma Research Inc., Clinical Reference Laboratory Inc., Eurofins Central Laboratory LLC, Frontage Laboratories Inc., Icon Central Labs, Interlab Central Lab Services, InVitro International, LabConnect LLC, Labcorp Drug Development India Private Limited, Medpace Clinical Research India Private Limited, MLM Medical Labs GmbH, Q2 Solutions Pty Ltd., Sonic Healthcare Limited, Synevo Central Lab, Acm Global Laboratories Private Limited, Altasciences, Barc Lab, BioIVT LLC, ICON plc, Intertek, LabNow LLC, Medidata Solutions, NAMSA LLC, Neoteryx, Northwell Health Labs, PAREXEL International, Pharm-Olam LLC, Pharmaceutical Product Development, PRA Health Sciences, Quest Diagnostics, IQVIA Co., Rho Inc.

What regional dynamics are shaping the future of the global central lab market?
North America was the largest region in the central lab market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the central lab market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Can Companies Use The Central Lab Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7317

Need Customized Data On Central Lab Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=7317&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company